• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前往肯尼亚旅行者的疟疾化学预防效果及其他决定因素

Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to Kenya.

作者信息

Muehlberger N, Jelinek T, Schlipkoeter U, von Sonnenburg F, Nothdurft H D

机构信息

Department of Public Health and Epidemiology, University of Munich, Germany.

出版信息

Trop Med Int Health. 1998 May;3(5):357-63. doi: 10.1046/j.1365-3156.1998.00235.x.

DOI:10.1046/j.1365-3156.1998.00235.x
PMID:9623940
Abstract

OBJECTIVE

To investigate the effectiveness of chemoprophylaxis and the determinants of malaria importation from Kenya.

METHOD

In a population-based case-control study, 51 travellers from Bavaria diagnosed with falciparum malaria imported from Kenya (cases) and a sample of 383 healthy Bavarian travellers returning from Kenya (controls) were interviewed. Data were analysed by multiple logistic regression.

RESULTS

Mefloquine (OR = 0.055; 95% CI 0.019-0.16) and chloroquine combined with proguanil (OR = 0.128; 95% CI 0.039-0.419) were highly protective against P. falciparum malaria, whereas other drugs were ineffective (OR = 1.225; 95% CI 0.536-2.803). Ineffective prophylaxis (10.4%) and non-prophylaxis (11.2%) were the main reasons for malaria importation. Travelling alone or with friends, male sex, and travel duration over 4 weeks could be identified as additional risk factors. The main reason for inadequate chemoprophylaxis was inappropriate medical advice (87.5%). Prophylaxis refusal occurred frequently despite correct advice (58.1%). Diagnosis was often delayed unnecessarily (27.5%).

CONCLUSION

Malaria importation from Kenya could be reduced substantially (34%) by eliminating inappropriate medical advice.

摘要

目的

调查化学预防的有效性以及从肯尼亚输入疟疾的决定因素。

方法

在一项基于人群的病例对照研究中,对51名来自巴伐利亚州、被诊断为从肯尼亚输入的恶性疟原虫疟疾的旅行者(病例)以及383名从肯尼亚返回的健康巴伐利亚旅行者样本(对照)进行了访谈。通过多因素逻辑回归分析数据。

结果

甲氟喹(比值比[OR]=0.055;95%可信区间[CI]0.019 - 0.16)以及氯喹与氯胍联合使用(OR = 0.128;95% CI 0.039 - 0.419)对恶性疟原虫疟疾具有高度保护作用,而其他药物则无效(OR = 1.225;95% CI 0.536 - 2.803)。无效预防(10.4%)和未预防(11.2%)是疟疾输入的主要原因。独自旅行或与朋友同行、男性以及旅行时间超过4周可被确定为额外的风险因素。化学预防不足的主要原因是不恰当的医疗建议(87.5%)。尽管有正确建议,仍经常出现预防措施被拒绝的情况(58.1%)。诊断常常被不必要地延迟(27.5%)。

结论

通过消除不恰当的医疗建议,可大幅减少从肯尼亚输入的疟疾(34%)。

相似文献

1
Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to Kenya.前往肯尼亚旅行者的疟疾化学预防效果及其他决定因素
Trop Med Int Health. 1998 May;3(5):357-63. doi: 10.1046/j.1365-3156.1998.00235.x.
2
Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.在前往东非的游客中,甲氟喹与其他疟疾化学预防方案的比较。
Lancet. 1993 May 22;341(8856):1299-303. doi: 10.1016/0140-6736(93)90814-w.
3
The effect of chemoprophylaxis on the timing of onset of falciparum malaria.化学预防对恶性疟发病时间的影响。
Trop Med Int Health. 1998 Apr;3(4):281-5. doi: 10.1046/j.1365-3156.1998.00222.x.
4
Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational data.英国旅行者疟疾化学预防对恶性疟原虫感染的效果:回顾性观察数据。
Travel Med Infect Dis. 2009 Nov;7(6):329-36. doi: 10.1016/j.tmaid.2009.10.002. Epub 2009 Nov 3.
5
Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.英国旅行者疟疾化学预防模型的比较获益。
Travel Med Infect Dis. 2014 Nov-Dec;12(6 Pt B):726-32. doi: 10.1016/j.tmaid.2014.08.005.
6
Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa.法国短期前往撒哈拉以南非洲旅行者对甲氟喹和氯喹+氯胍疟疾化学预防的依从性和耐受性
Trop Med Int Health. 1997 Oct;2(10):953-6. doi: 10.1046/j.1365-3156.1997.d01-153.x.
7
Malaria prophylaxis in travellers to tropical Africa.前往热带非洲旅行者的疟疾预防
Klin Wochenschr. 1990 Mar 5;68(5):277-80. doi: 10.1007/BF02116057.
8
[The proper use of antimalarial drugs currently available].[当前可用抗疟药物的合理使用]
Bull Soc Pathol Exot. 1998;91(5 Pt 1-2):493-6.
9
[Malaria--chemoprophylaxis 2001].[疟疾——2001年化学预防]
Ther Umsch. 2001 Jun;58(6):347-51. doi: 10.1024/0040-5930.58.6.347.
10
Drugs for preventing malaria in travellers.旅行者预防疟疾的药物。
Cochrane Database Syst Rev. 2009 Oct 7(4):CD006491. doi: 10.1002/14651858.CD006491.pub2.

引用本文的文献

1
Determinants of Compliance of Travelers with Vaccination and Malaria Prophylaxis at a Travel Clinic.旅行者在旅行诊所中接种疫苗和预防疟疾的依从性的决定因素。
J Korean Med Sci. 2019 Aug 26;34(33):e217. doi: 10.3346/jkms.2019.34.e217.
2
Human mobility and factors associated with malaria importation in Lusaka district, Zambia: a descriptive cross sectional study.赞比亚卢萨卡地区的人口流动及疟疾输入相关因素:一项描述性的横断面研究。
Malar J. 2018 Nov 3;17(1):404. doi: 10.1186/s12936-018-2554-4.
3
Economics of malaria prevention in US travelers to West Africa.
美国旅行者前往西非预防疟疾的经济学。
Clin Infect Dis. 2014 Jan;58(1):11-21. doi: 10.1093/cid/cit570. Epub 2013 Sep 6.
4
Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa.前往西非旅行者疟疾化学预防的成本效益分析。
BMC Infect Dis. 2010 Sep 22;10:279. doi: 10.1186/1471-2334-10-279.
5
Travel-related health problems of Hong Kong residents: Assessing the need for travel medicine services.香港居民与旅行相关的健康问题:评估旅行医学服务的需求。
Travel Med Infect Dis. 2006 Dec;4(6):324-31. doi: 10.1016/j.tmaid.2005.12.001. Epub 2006 Feb 17.
6
Modern malaria chemoprophylaxis.现代疟疾化学预防
Drugs. 2005;65(15):2091-110. doi: 10.2165/00003495-200565150-00003.
7
Malaria risk in travelers.旅行者中的疟疾风险。
Emerg Infect Dis. 2005 Mar;11(3):436-41. doi: 10.3201/eid1103.040677.
8
Antimalarial chemoprophylaxis in infants and children.婴幼儿的抗疟化学预防
Paediatr Drugs. 2001;3(2):113-21. doi: 10.2165/00128072-200103020-00004.